NTLA · Intellia Therapeutics, Inc. · Documents
$11.97
+0.13 (+1.10%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.66B
Shares
140.13M
Volume · Oct 20
3.42M
Avg daily vol (3M)
4.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-09 | — | |
| DEF 14A | — | 2024-04-29 | 2024-06-12 | |
| 8-K | — | 2024-04-15 | 2024-04-10 | |
| 8-K | — | 2024-03-22 | 2024-03-19 | |
| 8-K | — | 2024-02-23 | — | |
| 10-K | — | 2024-02-22 | 2023-12-31 | |
| 8-K | — | 2024-02-22 | — | |
| 8-K | — | 2024-02-01 | 2024-01-31 | |
| 8-K | — | 2024-01-04 | — | |
| 8-K | — | 2023-12-06 | 2023-12-05 | |
| 8-K | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-18 | — | |
| 8-K | — | 2023-10-03 | — | |
| 10-Q | — | 2023-08-03 | 2023-06-30 | |
| 8-K | — | 2023-08-03 | — | |
| 8-K | — | 2023-06-16 | 2023-06-14 | |
| 8-K | — | 2023-06-12 | 2023-06-11 | |
| 8-K | — | 2023-06-05 | — | |
| 8-K | — | 2023-05-04 | — | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| DEF 14A | — | 2023-05-01 | — | |
| 8-K | — | 2023-04-17 | 2023-04-14 | |
| 8-K | — | 2023-03-24 | 2023-03-23 | |
| 8-K | — | 2023-03-02 | — | |
| 10-K | — | 2023-02-23 | 2022-12-31 | |
| 8-K | — | 2023-02-23 | — | |
| 8-K | — | 2023-01-05 | — | |
| 8-K | — | 2022-12-01 | 2022-11-30 | |
| 8-K | — | 2022-11-14 | 2022-11-12 | |
| 8-K | — | 2022-11-07 | 2022-11-05 | |
| 10-Q | — | 2022-11-03 | 2022-09-30 | |
| 8-K | — | 2022-11-03 | — | |
| 8-K | — | 2022-09-16 | — | |
| 8-K | — | 2022-08-04 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-06-24 | — | |
| 8-K | — | 2022-06-15 | 2022-06-14 | |
| 8-K | — | 2022-05-05 | — | |
| 10-Q | — | 2022-05-05 | 2022-03-31 | |
| 8-K | — | 2022-05-03 | 2022-04-28 | |
| DEF 14A | — | 2022-05-02 | 2022-06-14 | |
| 8-K | — | 2022-03-04 | — | |
| 8-K | — | 2022-03-04 | 2022-02-28 | |
| 8-K | — | 2022-02-28 | — | |
| 10-K | — | 2022-02-24 | 2021-12-31 | |
| 8-K | — | 2022-02-24 | — | |
| 8-K | — | 2022-02-03 | 2022-02-02 | |
| 8-K | — | 2022-01-06 | — |
Showing 51–100 of 136 filings
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
38 filings
34 filers
Visit website
Investor relations